Standard BioTools CEO has 97K shares withheld for taxes

STANDARD BIOTOOLS INC.

Rhea-AI Filing Summary

STANDARD BIOTOOLS INC. (LAB) reported that President & CEO Michael Egholm had 97,627 shares of common stock withheld on August 20, 2026 to satisfy tax withholding obligations arising from the vesting of previously granted restricted stock units. Following this tax-withholding disposition, he directly holds 6,137,704 shares of common stock.

Insider Trade Summary

Tax Withholding: 97,627 shares

Tax Withholding 1 txn

Insider Egholm Michael

Role President & CEO

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1	97,627	$0.672	$66K

Holdings After Transaction: Common Stock — 6,137,704 shares (Direct)

Footnotes (1)

1. F1. The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024, March 21, 2025 and March 20, 2026, which grants were originally reported on Form 4s filed with the U.S. Securities and Exchange Commission on May 21, 2024, March 24, 2025 and April 8, 2026 respectively.

Key Figures

Shares withheld for taxes: 97,627 shares of Common Stock Transaction price per share: $0.6720 per share Shares held after transaction: 6,137,704 shares of Common Stock +1 more

4 metrics

Shares withheld for taxes 97,627 shares of Common Stock Withheld on August 20, 2026 to satisfy tax withholding obligations

Transaction price per share $0.6720 per share Price reported for the tax-withholding disposition of 97,627 shares

Shares held after transaction 6,137,704 shares of Common Stock Direct holdings of Michael Egholm following the August 20, 2026 transaction

ExercisePriceOrTaxLiabilityShares 97,627 shares Shares involved in payment of tax liability by delivering or withholding securities

Key Terms

restricted stock units, tax withholding obligations, transaction code F

3 terms

restricted stock units financial

"tax withholding obligations that arose upon the vesting of restricted stock units granted"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"shares were withheld from the reporting person to satisfy the tax withholding obligations"

transaction code F regulatory

"transaction code F describes Payment of tax liability by delivering or withholding"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did LAB report for Michael Egholm on this Form 4?

STANDARD BIOTOOLS INC. reported that President & CEO Michael Egholm had 97,627 shares of common stock withheld on August 20, 2026 to cover tax withholding obligations related to vesting restricted stock units.

Was the August 20, 2026 LAB Form 4 transaction a market sale by Michael Egholm?

No. The Form 4 states the 97,627 shares were withheld to pay tax withholding obligations upon vesting of restricted stock units, reported under transaction code F, rather than an open-market sale.

How many LAB shares does Michael Egholm hold after this Form 4 transaction?

After the tax-withholding disposition, Michael Egholm directly holds 6,137,704 shares of STANDARD BIOTOOLS INC. common stock, as reported in the Form 4 under total shares following the transaction.

What price per share is associated with the LAB shares withheld for taxes?

The Form 4 reports a transaction price of $0.6720 per share for the 97,627 common shares withheld to satisfy tax withholding obligations tied to vesting restricted stock units.

Were the LAB Form 4 transactions under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is not checked, and there is no footnote stating that the August 20, 2026 tax-withholding transaction was executed under a Rule 10b5-1 trading plan.

What awards led to the LAB tax-withholding share disposition?

The footnote explains the shares were withheld to satisfy taxes from vesting of restricted stock units granted to Michael Egholm on May 20, 2024, March 21, 2025, and March 20, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 05:05 PM EDT Accepted by SEC EDGAR 08/24/2026 - 05:04 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Egholm Michael

(Last) (First) (Middle)

C/O STANDARD BIOTOOLS INC.

50 MILK STREET, 10TH FLOOR

(Street)

BOSTON MASSACHUSETTS 02109

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
STANDARD BIOTOOLS INC. [ LAB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2026		F		97,627(1)	D	$0.672	6,137,704	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024, March 21, 2025 and March 20, 2026, which grants were originally reported on Form 4s filed with the U.S. Securities and Exchange Commission on May 21, 2024, March 24, 2025 and April 8, 2026 respectively.

	/s/ Michael Egholm by Tomone Tanaka, Attorney-in-Fact	08/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)